查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514894

IPV 疫苗市场，按疫苗类型、年龄层、分布、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

IPV Vaccines Market, By Vaccine Type, By Age Group, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年IPV疫苗市场规模为1.8945亿美元，2024年至2032年复合年增长率为8.3%。

IPV疫苗市场-市场动态

政府对免疫计划的资助增加推动了 IPV 疫苗的采用

多项措施证明，政府对免疫计画的资助增加显着促进了 IPV 疫苗的采用。例如，世界卫生组织 (WHO) 报告称，2020 年，由于加强了疫苗接种工作，全球脊髓灰质炎病例减少了 90%。此外，美国政府还拨款 2.37 亿美元用于 2021 年根除小儿麻痹工作，进一步强调了广泛分发 IPV 疫苗的承诺。这些大量投资对于确保 IPV 疫苗的可用性和可近性至关重要，最终推动更高的免疫率并使全球根除小儿麻痹的目标更接近现实。

IPV 疫苗市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.3% 左右的复合年增长率成长

根据疫苗类型细分，预计 IPV 疫苗将在 2023 年占据最大市场份额

依年龄层细分，2023年儿科为主导类型

按分布细分，公共疫苗接种计画是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

IPV 疫苗市场 - 細項分析：

全球 IPV 疫苗市场根据疫苗类型、年龄层、分布、最终用户和地区进行细分。

市场依疫苗类型分为两类：灭活小儿麻痹病毒疫苗和口服小儿麻痹病毒疫苗。与口服小儿麻痹病毒疫苗相比，灭活小儿麻痹病毒疫苗的安全性更高，加上政府的大力支持和旨在透过IPV 免疫计画根除小儿麻痹的国际努力，推动了灭活小儿麻痹质炎病毒疫苗领域的市场领先。

市场依年龄层分为两类：儿科和成人。儿科领域占有最高份额，这是由针对儿童的全球免疫计划推动的，该计划是按照医疗保健指南的规定，并得到广泛的政府和国际倡议的支持，以儿童为对象从小预防脊髓灰质炎。

IPV 疫苗市场 - 地理洞察

在北美，强而有力的政府支持和健全的医疗保健系统确保了 IPV 疫苗的高采用率。在全面免疫计画和欧洲疫苗行动计画等措施的推动下，欧洲也展现了重要的市场影响力。亚太地区，特别是印度和中国，由于人口众多以及各国政府以及世界卫生组织和联合国儿童基金会等国际组织支持的积极根除小儿麻痹运动，代表了一个迅速扩大的部分。非洲小儿麻痹发生率最高，儘管由于基础设施限制仍然存在挑战，但全球卫生组织在 IPV 疫苗分发方面做出了大量努力。在区域免疫活动和改善医疗服务的推动下，拉丁美洲市场呈现稳定成长。

IPV 疫苗市场-竞争格局：

IPV疫苗市场的特点是领先製药公司之间竞争激烈，每家公司都努力透过创新、策略联盟和广泛的分销网络来提高自己的市场份额。赛诺菲巴斯德、葛兰素史克和辉瑞等主要参与者占据市场主导地位，利用其广泛的研发能力和全球影响力推出有效和安全的 IPV 疫苗。这些公司经常与政府机构和世界卫生组织和联合国儿童基金会等全球卫生组织建立伙伴关係，以支持大规模免疫计画。在需求成长和政府支持政策的推动下，新兴企业和区域製造商也正在进入市场。此外，疫苗技术的进步，例如改进的储存解决方案和联合疫苗，正在加剧竞争，因为公司寻求差异化其产品并扩大其在已开发和发展中地区的业务。

最近的发展：

2023 年 12 月，Panacea Biotec 在印度推出了 EasyFourPol，这是一种全液体五价疫苗，可保护儿童免受白喉、破伤风、百日咳、小儿麻痹和 B 型流感嗜血桿菌感染。

2024 年 4 月，《商业标准》宣布印度有能力在 3-4 个月内供应全部 IPV，强调需要额外剂量以维持该国的无脊髓灰质炎状态。赛诺菲和印度血清研究所 (SII) 被确定为主要 IPV 疫苗供应商，其中赛诺菲贡献了约 80% 的需求。

目录

第 1 章：IPV 疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • IPV 疫苗市场片段（依疫苗类型）
    • 按年龄组别分類的 IPV 疫苗市场片段
    • 按分布分類的 IPV 疫苗市场片段
    • 最终用户的 IPV 疫苗市场摘要
    • 按国家/地区分類的 IPV 疫苗市场摘要
    • 按地区分類的 IPV 疫苗市场片段
  • 竞争洞察

第 3 章：IPV 疫苗主要市场趋势

  • IPV 疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • IPV 疫苗市场限制
    • 市场限制影响分析
  • IPV疫苗市场机会
  • IPV疫苗市场未来趋势

第 4 章：IPV 疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：IPV 疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：IPV 疫苗市场格局

  • 2023 年 IPV 疫苗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：IPV 疫苗市场 - 依疫苗类型

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 灭活小儿麻痹病毒疫苗 (IPV)
    • 口服小儿麻痹病毒疫苗 (OPV)

第 8 章：IPV 疫苗市场 - 按年龄组

  • 概述
    • 按年龄组别分類的细分市场占有率分析
    • 儿科
    • 成年人

第 9 章：IPV 疫苗市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 公共疫苗接种计划
    • 私人疫苗接种诊所
    • 药局
    • 网路药局

第 10 章：IPV 疫苗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 公共卫生机构
    • 其他的

第 11 章：IPV 疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • IPV 疫苗北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疫苗类型）
    • 北美市场规模和预测（按年龄组）
    • 北美市场规模和预测（按分布）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲 IPV 疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按疫苗类型）
    • 欧洲市场规模和预测（按年龄层）
    • 欧洲市场规模和预测（按分布）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区 IPV 疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依疫苗类型）
    • 亚太地区市场规模与预测（依年龄层）
    • 亚太地区市场规模与预测（按分布）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲 IPV 疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按疫苗类型）
    • 拉丁美洲市场规模与预测（按年龄层）
    • 拉丁美洲市场规模与预测（按分布）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲 IPV 疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疫苗类型）
    • 中东和非洲市场规模及预测（按年龄层）
    • 中东和非洲市场规模及预测（按分布）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - IPV 疫苗产业

  • 竞争仪表板
  • 公司简介
    • Sanofi Pasteur
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Panacea Biotec Ltd.
    • Bio Farma
    • Sinovac Biotech Ltd.
    • Astellas Pharma Inc.
    • Sinopharm Group Co., Ltd.
    • Valneva SE
    • Innovax
    • LG Chem
    • PT Bio Farma (Persero)
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3035

REPORT HIGHLIGHT

IPV Vaccines Market size was valued at USD 189.45 million in 2023, expanding at a CAGR of 8.3% from 2024 to 2032.

The IPV Vaccines Market, defined as the sector dedicated to inactivated poliovirus vaccines used for polio prevention, is experiencing growth driven by global immunization initiatives and increasing awareness of polio eradication. The robust government vaccination programs, support from organizations like WHO and UNICEF, and rising incidences of polio in certain regions are propelling the market demand. However, market growth is restrained by the high costs of vaccine development and distribution challenges in remote areas. Nonetheless, opportunities exist in the development of combination vaccines, advancements in vaccine storage and delivery technologies, and increasing investments in healthcare infrastructure in emerging economies.

IPV Vaccines Market- Market Dynamics

Increased Government Funding for Immunization Programs Fuels Adoption of IPV Vaccines

Increased government funding for immunization programs is significantly boosting the adoption of IPV vaccines, as evidenced by initiatives. For instance, in 2020, the World Health Organization (WHO) reported a 90% reduction in polio cases worldwide due to enhanced vaccination efforts. Additionally, the U.S. government allocated USD 237 million to polio eradication efforts in 2021, further emphasizing the commitment to widespread IPV vaccine distribution. These substantial investments are crucial in ensuring the availability and accessibility of IPV vaccines, ultimately driving higher immunization rates and bringing the goal of global polio eradication closer to reality.

IPV Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, IPV vaccines were predicted to show maximum market share in the year 2023

Based on Age Group segmentation, Pediatrics was the leading type in 2023

Based on distribution segmentation, Public Vaccination Programs were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

IPV Vaccines Market- Segmentation Analysis:

The Global IPV vaccine market is segmented based on Vaccine Type, Age Group, Distribution, End-User, and Region.

The market is divided into two categories based on Vaccine Type: Inactivated Poliovirus Vaccine, and Oral Poliovirus Vaccine. The Inactivated Poliovirus Vaccine segment led the market, driven by its enhanced safety profile compared to the Oral Poliovirus Vaccine, alongside strong government support and international efforts aimed at polio eradication through IPV immunization programs.

The market is divided into two categories based on Age Group: Pediatrics, and Adults. The pediatrics segment holds the highest share, driven by global immunization programs targeting children to prevent polio from an early age, as mandated by healthcare guidelines and supported by extensive government and international initiatives.

IPV Vaccines Market- Geographical Insights

In North America, strong government support and robust healthcare systems ensure high adoption rates of IPV vaccines. Europe also demonstrates a significant market presence, driven by comprehensive immunization programs and initiatives like the European Vaccine Action Plan. Asia-Pacific, particularly India and China, represents a rapidly expanding segment due to large populations and aggressive polio eradication campaigns supported by both governments and international organizations like WHO and UNICEF. Africa, facing the highest polio prevalence, sees substantial efforts in IPV vaccine distribution funded by global health organizations, although challenges remain due to infrastructural limitations. Latin America shows steady market growth fueled by regional immunization drives and improving healthcare access.

IPV Vaccines Market- Competitive Landscape:

The IPV vaccine market is characterized by strong competition among leading pharmaceutical companies, each striving to enhance their market share through innovation, strategic alliances, and extensive distribution networks. Major players such as Sanofi Pasteur, GlaxoSmithKline, and Pfizer dominate the market, leveraging their extensive R&D capabilities and global reach to introduce effective and safe IPV vaccines. These companies frequently engage in partnerships with government bodies and global health organizations like WHO and UNICEF to support large-scale immunization programs. Emerging players and regional manufacturers are also entering the market, driven by increasing demand and supportive governmental policies. Additionally, advancements in vaccine technology, such as improved storage solutions and combination vaccines, are intensifying competition as companies seek to differentiate their offerings and expand their presence in both developed and developing regions.

Recent Developments:

In December 2023, Panacea Biotec launched EasyFourPol, a fully liquid pentavalent vaccine in India, safeguarding children against diphtheria, tetanus, pertussis, polio, and Haemophilus influenza type B infections.

In April 2024, The Business Standard announced India's capability to supply its entire IPV within 3-4 months, emphasizing the necessity of additional doses to sustain the nation's polio-free status. Sanofi and Serum Institute of India (SII) are identified as the primary IPV vaccine suppliers, with Sanofi contributing approximately 80% of the requirement.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IPV VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi Pasteur

GlaxoSmithKline plc

Pfizer Inc.

Merck & Co., Inc.

Johnson & Johnson

Serum Institute of India Pvt. Ltd.

Bharat Biotech

Panacea Biotec Ltd.

Bio Farma

Sinovac Biotech Ltd.

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Valneva SE

Innovax

LG Chem

PT Bio Farma (Persero)

Others

GLOBAL IPV VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated Poliovirus Vaccine (IPV)
  • Oral Poliovirus Vaccine (OPV)

GLOBAL IPV VACCINES MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Pediatrics
  • Adults

GLOBAL IPV VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Public Vaccination Programs
  • Private Vaccination Clinics
  • Pharmacies
  • Online Pharmacies

GLOBAL IPV VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Public Health Agencies
  • Others

GLOBAL IPV VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. IPV Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. IPV Vaccines Market Snippet by Vaccine Type
    • 2.1.2. IPV Vaccines Market Snippet by Age Group
    • 2.1.3. IPV Vaccines Market Snippet by Distribution
    • 2.1.4. IPV Vaccines Market Snippet by End-User
    • 2.1.5. IPV Vaccines Market Snippet by Country
    • 2.1.6. IPV Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. IPV Vaccines Key Market Trends

  • 3.1. IPV Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. IPV Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. IPV Vaccines Market Opportunities
  • 3.4. IPV Vaccines Market Future Trends

4. IPV Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. IPV Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. IPV Vaccines Market Landscape

  • 6.1. IPV Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. IPV Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Inactivated Poliovirus Vaccine (IPV)
    • 7.1.3. Oral Poliovirus Vaccine (OPV)

8. IPV Vaccines Market - By Age Group

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Age Group, 2023 & 2032 (%)
    • 8.1.2. Pediatrics
    • 8.1.3. Adults

9. IPV Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Public Vaccination Programs
    • 9.1.3. Private Vaccination Clinics
    • 9.1.4. Pharmacies
    • 9.1.5. Online Pharmacies

10. IPV Vaccines Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Public Health Agencies
    • 10.1.5. Others

11. IPV Vaccines Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. IPV Vaccines Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. IPV Vaccines Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. IPV Vaccines Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. IPV Vaccines Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. IPV Vaccines Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- IPV Vaccines Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Sanofi Pasteur
    • 12.2.2. GlaxoSmithKline plc
    • 12.2.3. Pfizer Inc.
    • 12.2.4. Merck & Co., Inc.
    • 12.2.5. Johnson & Johnson
    • 12.2.6. Serum Institute of India Pvt. Ltd.
    • 12.2.7. Bharat Biotech
    • 12.2.8. Panacea Biotec Ltd.
    • 12.2.9. Bio Farma
    • 12.2.10. Sinovac Biotech Ltd.
    • 12.2.11. Astellas Pharma Inc.
    • 12.2.12. Sinopharm Group Co., Ltd.
    • 12.2.13. Valneva SE
    • 12.2.14. Innovax
    • 12.2.15. LG Chem
    • 12.2.16. PT Bio Farma (Persero)
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE IPV Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global IPV Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Age Group Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global IPV Vaccines Market, by Age Group 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global IPV Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global IPV Vaccines Market, by End-User 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global IPV Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE IPV Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2032
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Age Group segment market share analysis, 2023 & 2032
  • FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America IPV Vaccines Market share and leading players, 2023
  • FIGURE Europe IPV Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific IPV Vaccines Market share and leading players, 2023
  • FIGURE Latin America IPV Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa IPV Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe IPV Vaccines Market share analysis by country, 2023
  • FIGURE Germany IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific IPV Vaccines Market share analysis by country, 2023
  • FIGURE India IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IPV Vaccines Market share analysis by country, 2023
  • FIGURE Brazil IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IPV Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)